IDH1/2 but not DNMT3A mutations are suitable targets for minimal residual disease monitoring in acute myeloid leukemia patients: a study by the Acute Leukemia French Association
法国急性白血病协会的一项研究表明,IDH1/2 突变而非 DNMT3A 突变是急性髓系白血病患者微小残留病灶监测的合适靶点。
期刊:Oncotarget
影响因子:
doi:10.18632/oncotarget.5645
Debarri, Houria; Lebon, Delphine; Roumier, Christophe; Cheok, Meyling; Marceau-Renaut, Alice; Nibourel, Olivier; Geffroy, Sandrine; Helevaut, Nathalie; Rousselot, Philippe; Gruson, Bérengère; Gardin, Claude; Chretien, Marie-Lorraine; Sebda, Shéhérazade; Figeac, Martin; Berthon, Céline; Quesnel, Bruno; Boissel, Nicolas; Castaigne, Sylvie; Dombret, Hervé; Renneville, Aline; Preudhomme, Claude